Artemis Resources (LON: ARV) has received commitments to raise A$4.75m at A$0.004/share. This will fund gold exploration at Carlow, Titan and Cassowary. The share price rebounded 10.8% to 0.21p.
Sunrise Resources (LON: SRES) has signed an option agreement with a US company over the sale of the non-core Hazen project in Nevada. The option fee is $20,000 and the consideration if the 90-day option is exercised is $900,000. A payment of $7,500 is due if there is a 30-day extension to option. The book value is less than £24,000. The share price rose 8.33% to 0.02p.
Strategic communications services provider Aeoema Communications (LON: AEO) says revenues and profit for the 12-month period to June 2025 will be at the upper end of expectations. Underlying pre-tax profit will rise from £437,000 to more than £600,000, helped by cost reductions. Cash was £4.1m at the end of June 2025 and a dividend will be announced after the full results are published. The financial year end is changing to December. The share price increased 8.42% to 51.5p.
Anglo Asian Mining (LON: AAZ) has commenced production at the Demirli copper mine and production will ramp up during the rest of the year. The Demirli open pit mine could produce 4,000 tonnes of copper in 2025 and that is expected to rise to 15,000 tonnes of copper in 2026. There is potential for extensions to the existing area. The share price improved 6.02% to 176p.
Unilever has commissioned additional work from Aptamer Group (LON: APTA) relating to the use of Optimers in deodorants. This will generate additional revenues under the exiting agreement. The share price is 5.26% higher at 0.4p.
FALLERS
Jangada Mines (LON: JAN) has signed a heads of term for the potential acquisition of 33.3% of MTGOLD MINERACAO, the owner of the Paranaita gold project in Brazil, with an option to increase the stake to 50.1%. The initial cost is £1m worth of shares and £250,000 in cash. Jangada Mines has raised £800,000 at 0.6p/share and directors are converting £350,000 of fees into shares at the same price. Paranaita has a measured, indicated and inferred gold resource is 210,000 ounces at a grade of 3.165g/t. The share price slumped 35% to 0.65p.
Organ transplant diagnostics developer Verici Dx (LON: VRCI) is planning a placing and subscription to raise a minimum of £5m at 0.5p/share, plus a retail offer of up to £500,000. The minimum offer subscription is £100, and it closes on 28 July. The cash will fund additional sales personnel for the commercialisation of Tutiva, a test for post-transplant rejection. It will also finance product development and working capital. There were 292 tests undertaken in the quarter to June 2025. The effective date for Medicare billing ha been changed to 21 November 2024, enabling the earlier billing of the tests. This boosts revenues. The share price dived 37.1% to 0.55p.
Wound healing technology developer AOTI Inc (LON: AOTI) expects interim revenues to increase from $26.3m to at least $31m. However, growth has slowed because of US government spending initiatives that caused disruption. Veterans Administration employee numbers were reduced and this disruption is expected to continue in the second half, but there hould be improvement before the end of the year. AOTI has been awarded a California Medicaid provider ID, which is the third state to grant this. California has 14.9 million enrolled in Medicaid. However, the latest US legislation could hamper the progress of overall Medicaid revenues. The share price declined 22.2% to 70p.
Oil and gas producer Empyrean Energy (LON: EME) has raised £1m at 0.08p/share. This will fund the company’s share of development costs relating to the 8.5% interest in the Mako gas field, offshore Indonesia. The share price fell 14.4% to 0.09p.